BioSpace News Archive

Drug Development

Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease

Voyager Therapeutics, Inc. today announced that the first participants were dosed in a Phase 1a single ascending dose (SAD) trial of VY-TAU01, an investigational anti-tau antibody developed to inhibit the spread of pathological tau in Alzheimer’s disease.

May 16, 2024
·
6 min read
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®

Axogen, Inc. is pleased to announce that it has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License Application (BLA) for licensure of Avance Nerve Graft ® on May 15, 2024.

May 16, 2024
·
7 min read
First Wave BioPharma Changes Name to Entero Therapeutics

Entero Therapeutics, Inc. today unveiled its new corporate name and website.

May 16, 2024
·
4 min read
Deals

Monte Rosa Therapeutics Announces Pricing of $100 Million Underwritten Public Offering

Monte Rosa Therapeutics, Inc. today announced the pricing of an underwritten public offering of 10,638,476 shares of its common stock at a public offering price of $4.70 per share.

May 16, 2024
·
5 min read
Business

Pendopharm renews distribution agreement with Anika Therapeutics Inc. for Cingal, Monovisc, and Orthovisc

Pendopharm is pleased to announce the renewal of its exclusive distribution agreement with Anika Therapeutics Inc (NASDAQ: ANIK) (Anika) for Cingal ® , Monovisc ® and Orthovisc ® through the end of 2030.

May 16, 2024
·
2 min read
Genetown

Liberate Bio Announces Presentation to Update on Advancements on their RAPTOR LNP Platform

Liberate Bio, Inc. announced an oral presentation demonstrating the success of their RAPTOR™ screening platform and its first generation of extrahepatic lipid nanoparticles at the Oligonucleotide and Peptide Therapeutics 2024 (TIDES) being held May 14-17, 2024, in Boston, Massachusetts.

May 16, 2024
·
2 min read
Genetown

Zai Lab Announces Participation in May and June Investor Conferences

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in May and June 2024.

May 16, 2024
·
1 min read
Business

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

CollPlant Biotechnologies today announced that it will report financial results for the first quarter of 2024 on Wednesday, May 29, 2024, before the opening of the U.S. financial markets.

May 16, 2024
·
2 min read
Business

Nucleai Appoints Vikas Ahuja as Vice President of Strategic Partnerships to Enable Diagnostic Deployment and Commercialization at Scale

Nucleai announced today the expansion of its executive leadership team with the appointment of Vikas Ahuja as Vice President of Strategic Partnerships.

May 16, 2024
·
3 min read
Business

AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update

AIM ImmunoTech Inc. today reported its financial results for the first quarter 2024.

May 16, 2024
·
4 min read